Incyte (INCY) Long-Term Investments (2014 - 2026)

Incyte (INCY) reported Long-Term Investments of $54.6 million for Q1 2026, up 212.56% on a YoY basis from $17.5 million in Q1 2025, and up 13.73% quarter-over-quarter from $48.0 million in Q4 2025.

Incyte (INCY) Long-Term Investments (2014 - 2026) Analysis & Trends

Incyte has reported Long-Term Investments for 13 years, with the latest figure at $54.6 million in Q1 2026.

  • For the quarter ending Q1 2026, Long-Term Investments rose 212.56% year-over-year to $54.6 million; the trailing twelve-month figure through Mar 2026 stood at $54.6 million (up 212.56% YoY), and the FY2025 full-year result was $48.0 million, up 155.08% from the prior year.
  • Long-Term Investments for Q1 2026 stood at $54.6 million, up from $48.0 million in the prior quarter.
  • The five-year high for Long-Term Investments was $287.7 million in Q1 2024, with the low at $1.6 million in Q3 2022.
  • Historically, Long-Term Investments has averaged $85.0 million across 5 years, with a median of $48.0 million in 2025.
  • Annual changes were most pronounced in 2022 — Long-Term Investments tumbled 99.17% — and 2023, when it jumped 9497.94%.
  • Incyte's Long-Term Investments stood at $133.7 million in 2022, then surged by 40.43% to $187.7 million in 2023, then slumped by 89.98% to $18.8 million in 2024, then surged by 155.08% to $48.0 million in 2025, then rose by 13.73% to $54.6 million in 2026.
  • The last three Long-Term Investments figures came in at $54.6 million (Q1 2026), $48.0 million (Q4 2025), and $21.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 5.17 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.75 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Incyte 19.62 Bn 15.60 Bn 1.17 Bn 54.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 54.58 Mn
Dec 31, 2025 47.99 Mn
Sep 30, 2025 21.87 Mn
Jun 30, 2025 13.31 Mn
Mar 31, 2025 17.46 Mn
Dec 31, 2024 18.81 Mn
Sep 30, 2024 27.57 Mn
Jun 30, 2024 29.67 Mn
Mar 31, 2024 287.66 Mn
Dec 31, 2023 187.72 Mn
Sep 30, 2023 153.66 Mn
Jun 30, 2023 170.32 Mn
Mar 31, 2023 128.31 Mn
Dec 31, 2022 133.68 Mn
Sep 30, 2022 1.60 Mn
Jun 30, 2022 149.78 Mn
Mar 31, 2022 1.70 Mn
Dec 31, 2021 221.27 Mn
Sep 30, 2021 192.10 Mn
Jun 30, 2021 220.69 Mn